Efficacy and safety of Lavender aromatherapy on sleep quality and metabolic parameters of patients with diabetes mellitus type II and insomnia
Not Applicable
- Conditions
- diabetes-insomnia.
- Registration Number
- IRCT201703117297N3
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
• Age: 25-65 years old. Fasting Blood Sugar between 70-130. 2 hour post prandial glucose less than 180.
HbA1C less than 7. Sleep disorder according to pittsburgh Insomnia Rating Scale more than 5. Exclusion criteria: Any systemic illnesses. Use of sedative or antidepressant drugs. Pregnancy. Lactation. History of allergic reaction to Lavender. History of allergic rhinitis, asthma and respiratory disorders. Anosmia. Headache that start with smell. Cigarette smocking or substance abuse. Hospitalization or surgery within 1 months ago.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pittsburgh Insomnia Rating Scale. Timepoint: before intervention- 4 week after drug- 4 week after placebo. Method of measurement: pittsburgh Insomnia Rating Scale.
- Secondary Outcome Measures
Name Time Method